PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.25%
Revenue growth 1.25-1.5x 9843.T's 3.65%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
6.66%
Gross profit growth similar to 9843.T's 7.03%. Walter Schloss would assume both firms track common industry trends.
45.88%
EBIT growth above 1.5x 9843.T's 21.82%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
51.13%
Operating income growth above 1.5x 9843.T's 14.91%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
46.91%
Net income growth above 1.5x 9843.T's 25.22%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
46.89%
EPS growth above 1.5x 9843.T's 24.90%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
46.89%
Diluted EPS growth above 1.5x 9843.T's 24.90%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Share reduction while 9843.T is at 0.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
68.51%
10Y revenue/share CAGR at 50-75% of 9843.T's 125.43%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
64.78%
5Y revenue/share CAGR 1.25-1.5x 9843.T's 57.23%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
35.69%
3Y revenue/share CAGR 1.25-1.5x 9843.T's 26.74%. Bruce Berkowitz might see better product or regional expansions than the competitor.
100.00%
Positive long-term OCF/share growth while 9843.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
202.11%
Net income/share CAGR 1.25-1.5x 9843.T's 175.51%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
95.22%
5Y net income/share CAGR at 75-90% of 9843.T's 108.24%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
40.35%
3Y net income/share CAGR similar to 9843.T's 37.78%. Walter Schloss would attribute it to shared growth factors or demand patterns.
201.46%
10Y equity/share CAGR at 50-75% of 9843.T's 322.73%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
125.07%
5Y equity/share CAGR above 1.5x 9843.T's 77.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
58.34%
3Y equity/share CAGR 1.25-1.5x 9843.T's 44.73%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.90%
Firm’s AR is declining while 9843.T shows 19.03%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.06%
Inventory is declining while 9843.T stands at 10.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.11%
Asset growth well under 50% of 9843.T's 2.80%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.35%
1.25-1.5x 9843.T's 2.82%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-4.77%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
We cut SG&A while 9843.T invests at 3.65%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.